✦ LIBER ✦

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD

✍ Scribed by Bain, Earle E; Robieson, Weining; Pritchett, Yili; Garimella, Tushar; Abi-Saab, Walid; Apostol, George; McGough, James J; Saltarelli, Mario D

Book ID: 120057962
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 473 KB
Volume: 38
Category: Article
ISSN: 1470-634X
DOI: 10.1038/npp.2012.194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled Phase 2 study of α4β2 agonist ABT-894 in adults with ADHD

✍ Earle Bain; Weining Robieson; Tushar Garimella; Walid Abi-Saab; George Apostol; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy and safety of the novel α4β2neu

Efficacy and safety of the novel α4β2neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

✍ George Apostol; Walid Abi-Saab; Christopher J. Kratochvil; Lenard A. Adler; Wein 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 321 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

✍ Aurelija Jucaite, John Öhd, Alexandra S. Potter, Judith Jaeger… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB

GLANCE: Results of a phase 2, randomized

GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study

✍ Goodman, A. D.; Rossman, H.; Bar-Or, A.; Miller, A.; Miller, D. H.; Schmierer, K 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 408 KB

A phase 2, randomized, double-blind, pla

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis

✍ Vlad Ratziu; Muhammad Y. Sheikh; Arun J. Sanyal; Joseph K. Lim; Hari Conjeevaram 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

In nonalcoholic steatohepatitis (NASH), the extent of hepatocyte apoptosis correlates with disease severity. Reducing hepatocyte apoptosis with the selective caspase inhibitor GS-9450 has a potential for altering the course of the liver disease. In this phase 2, double-blind study, 124 subjects with

Relapse Prevention in Pediatric Patients

Relapse Prevention in Pediatric Patients With ADHD Treated With Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study

✍ MICHELSON, DAVID; BUITELAAR, JAN K.; DANCKAERTS, MARINA; GILLBERG, CHRISTOPHER; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB